Synsorb Biotech Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Synsorb Biotech

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bruce Mayo who wrote (6)	12/9/1996 8:11:00 PM
From: Fred J Bealle	of 32

Hi Bruce, welcome! It's lonely being a Maytag repairman. The Investor's Digest of Canada (subscription $37 special: 800 430 1897) of November 8 96 had a mention of Synsorb on page 435: "Shares may hit $20 by end of '97". Also have target of $33.90 cdn in 2001. The Yorkton Securities analysis was done by Wayne Schnarr when Syb was 5.50. It mentions a treatment fee of $5000 per patient, using Synsorb Pk. The alternative is dooming a child to lifelong kidney failure or (7%) death. Very compelling sales pitch. I'm not sure why I'm hyping this stock. I bought in at 2.80 and sold 90% by $5 region! I dearly want it to go down to $5 so I can buy in again. Believe this: the stock has proven itself. If it DOES go down to $8, I will buy. If it goes down to $1, I will buy! 1.phase III started in Canada in June 2.phase III will start in US late in 96. 3.it has Japanese support (not surprising for the land of raw-meat-eaters) 4.the whole world is becoming antibiotic-resistant. Products like synsorb are truly proof against such lethal resistance. Should you sell? NO, NO, NO! A thousand times no. Better to sell your car and walk. Do not sell Synsorb on weakness. Rather, buy on weakness in the price. Learn from my blunder. I am hoping for that weakness. Fred

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next